Journal article
Zied Ferjaoui, Sara Nahle, R. Schneider, H. Kerdjoudj, D. Mertz, F. Quilès, K. Ferji, E. Gaffet, H. Alem
Advanced Materials Interfaces, 2023
Advanced Materials Interfaces, 2023
Semantic Scholar
DOI
Cite
Cite
APA
Click to copy
Ferjaoui, Z., Nahle, S., Schneider, R., Kerdjoudj, H., Mertz, D., Quilès, F., … Alem, H. (2023). Development of Folate‐Superparamagnetic Nanoconjugates for Inhibition of Cancer Cell Proliferation. Advanced Materials Interfaces.
Chicago/Turabian
Click to copy
Ferjaoui, Zied, Sara Nahle, R. Schneider, H. Kerdjoudj, D. Mertz, F. Quilès, K. Ferji, E. Gaffet, and H. Alem. “Development of Folate‐Superparamagnetic Nanoconjugates for Inhibition of Cancer Cell Proliferation.” Advanced Materials Interfaces (2023).
MLA
Click to copy
Ferjaoui, Zied, et al. “Development of Folate‐Superparamagnetic Nanoconjugates for Inhibition of Cancer Cell Proliferation.” Advanced Materials Interfaces, 2023.
BibTeX Click to copy
@article{zied2023a,
title = {Development of Folate‐Superparamagnetic Nanoconjugates for Inhibition of Cancer Cell Proliferation},
year = {2023},
journal = {Advanced Materials Interfaces},
author = {Ferjaoui, Zied and Nahle, Sara and Schneider, R. and Kerdjoudj, H. and Mertz, D. and Quilès, F. and Ferji, K. and Gaffet, E. and Alem, H.}
}
Abstract
Here, a versatile strategy to engineer smart theranostic nanocarriers is reported. The core/shell nanosystem is composed of a superparamagnetic iron oxide (Fe3−δO4) nanoparticle (NP) core bearing the biocompatible thermo‐responsive poly(2‐(2‐methoxy)ethyl methacrylate‐oligo(ethylene glycol methacrylate), P(MEO2MAx‐OEGMA100−x) copolymer (where x and 100‐x represent the molar fractions of MEO2MA and OEGMA, respectively). Folic acid (FA) is end‐conjugated to the P(MEO2MAx‐OEGMA100−x) copolymer, leading to Fe3−δO4@P(MEO2MAx‐OEGMA100−x)‐FA, to facilitate active targeting of NPs to cancer cells. A highly potent hydrophobic anticancer agent doxorubicin (DOX) is incorporated in the thermo‐responsive P(MEO2MAx‐OEGMAy) brushes via supramolecular interactions to increase its solubility and the assessment of therapeutic potentials. These experiments confirm the magnetic hyperthermia properties of nanocarrier and reveal that only a small amount (10% ± 4%) of DOX is diffused at room temperature, while almost full drug (100%) is released after 52 h at 41 °C. Interestingly, it is found that P(MEO2MA60‐OEGMA40) polymers offer to NPs a promising stealth behavior against Human Serum Albumin and Fibrinogen model proteins.